HEALTHEQUITY, INC.
For the period ended Oct 31, 2025. Filed Dec 3, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 31, 2025 · Filed Dec 3, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other information
Rule 10b5-1 plan elections
Except as described below, none of the Company's directors or officers adopted orterminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408(c) of Regulation S-K) during the fiscal quarter ended October 31, 2025.
On October 14, 2025, Michael Fiore, our Executive Vice President and Chief Commercial Officer, entered into a Rule 10b5-1 trading arrangement (the “Fiore Arrangement”). The Fiore Arrangement provides for the sale, between January 13, 2026 and December 15, 2026, of up to 19,532 aggregate shares of the Company’s common stock held directly by Mr. Fiore. The Fiore Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
-37-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.